Category: Pharma News

According to in-vitro investigations, Tremfya shows a distinct binding mechanism from risankizumab, according to Janssen Pharma.

Further findings from in vitro MODIF-Y tests from the Janssen Pharmaceutical Companies of Johnson & Johnson reinforce the idea that not all IL-23 inhibitors work the same way by showing that Tremfya (guselkumab) and risankizumab have different binding mechanisms. According…

Faricimab, an eye medicine from Roche, should be approved with a local phase III trial waiver, according to the SEC.

Faricimab intravitreal injection, manufactured by Swiss multinational pharmaceutical company Roche, has been approved for import and marketing in India, with the local phase III clinical trial being waived subject to conditions, according to the expert committee’s recommendation. To treat Neto…

For the treatment of second-degree burns, the US FDA approves the medical device InnovaBurn from Convatec.

The InnovaBurn placental extracellular matrix medical device from Convatec has been approved by the US Food and Drug Administration for the care of difficult surgical wounds and burns, including partial-thickness second-degree burns. According to the American Burn Association’s ameriburn.org, which…

Laevoroc’s LR 09 is given orphan medication classification by the US FDA to treat leukaemia relapse following allogeneic stem cell transplant.

LR 09, a novel metabolic immune checkpoint inhibitor, has been given Orphan Drug Designation by the US Food and Drug Administration (FDA) for the treatment of patients with haematological malignancies who have been identified with a relapse following allogeneic stem…

In order to treat AS and RA, Enzene Biosciences has started selling biosimilar adalimumab commercially in India.

Adalimumab has started to be sold commercially for the treatment of rheumatoid arthritis and ankylosing spondylitis, according to Enzene Biosciences Ltd., a technology-focused biotechnology business based in Pune. This is the business’s fourth biosimilar launch in recent years, and the…

Back to top
WhatsApp Join Telegram